Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / pi-agreement-aldridge.docx
pi-agreement-aldridge.docx
Parties
Penterra Pharmaceuticals Corp
Townsend Independent Auditors LLP
Dates
June 28, 2023
January 15, 2023
August 14, 2023
April 1, 2023
March 31, 2024
Amounts
$4.2
$52,000
$13,000
$1,500,000
$500,000
$15,000,000
$25,000,000
$75,000,000
$10,000,000
$50,000,000
Obligations
NOW, THEREFORE, in consideration of the mutual promises, covenants, and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows: Right-click to update Table of Contents ARTICLE 1 — DEFINITIONS Capitalized terms used in this Agreement and not otherwise defined herein shall have the meanings ascribed to them in the MCTA
The following terms shall have the meanings set forth below: 1
The confidentiality obligations with respect to Confidential Information shall remain in effect for a period of ten (10) years from the date of each disclosure
Aldridge shall serve as the lead clinical investigator for the CLARION trial across all participating Veridian Network sites and shall bear overall scientific and medical responsibility for the integrity and quality of the Study as a whole
5 shall remain in effect notwithstanding the expiration or termination of this Agreement
This Agreement is supplemental to and shall be read in conjunction with the MCTA, the Individual Site Agreement for Site 001, and the IP Side Letter dated June 28, 2023